Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibition for Metabolic and Virological Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a highly specific and competitive inhibitor of heme oxygenase (HO), showing a Ki of 14 nM in vitro and proven in vivo efficacy at 1 pmol/kg in animal models [APExBIO]. This compound reduces hepatic, renal, and splenic HO activity and serum bilirubin levels in neonatal hyperbilirubinemia models [Koyaweda et al., 2026]. Its chemical stability, solubility (up to 0.5 mg/ml in DMSO), and clear storage guidelines make it a reliable tool for research. Tin Mesoporphyrin IX (chloride) is widely utilized to dissect mechanisms in heme metabolism, metabolic disease, insulin resistance, metaflammation, and viral pathogenesis. No clinical trials are reported to date, and its use is restricted to preclinical and biochemical research settings.

Biological Rationale

Heme oxygenase (HO) is the rate-limiting enzyme responsible for catalyzing the degradation of heme into biliverdin, ferrous iron, and carbon monoxide [Koyaweda et al., 2026]. The HO-1 isoform is inducible and plays a critical role in cellular response to oxidative stress, inflammation, and metabolic regulation. Modulation of HO activity is a validated approach for studying pathophysiological processes in metabolic diseases, insulin resistance, and metaflammation. In virology, HO-1 upregulation has been linked to suppression of hepatitis B virus (HBV) replication via reactive oxygen species (ROS) modulation and impaired viral morphogenesis [Koyaweda et al., 2026]. Inhibiting HO activity with compounds such as Tin Mesoporphyrin IX (chloride) allows researchers to interrogate these pathways in controlled settings.

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) is a synthetic porphyrin derivative that functions as a competitive inhibitor of heme oxygenase [APExBIO]. It binds to the active site of HO with high affinity (Ki = 14 nM), displacing heme and preventing its enzymatic degradation. Inhibition of HO results in decreased biliverdin, iron, and carbon monoxide production. This blockade alters cellular redox status and impacts downstream signaling, including the regulation of tryptophan pyrrolase activity and attenuation of HO-1-mediated ROS modulation. The precise molecular interaction involves coordination between the tin atom and the heme binding pocket, conferring selectivity and potency. In animal studies, Tin Mesoporphyrin IX (chloride) administered at 1 pmol/kg was sufficient to suppress HO activity in hepatic, renal, and splenic tissues for extended periods [Koyaweda et al., 2026].

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) exhibits a Ki of 14 nM for HO inhibition in vitro, indicating high potency [APExBIO].
• In vivo administration at 1 pmol/kg inhibits hepatic, renal, and splenic HO activity for extended periods in animal models [Koyaweda et al., 2026].
• Reduces serum bilirubin levels in neonatal hyperbilirubinemia models, confirming efficacy in heme catabolism modulation [Koyaweda et al., 2026].
• Increases heme saturation of hepatic tryptophan pyrrolase, demonstrating downstream metabolic impact [APExBIO].
• Highly soluble up to 0.5 mg/ml in DMSO and 1 mg/ml in dimethyl formamide, facilitating assay integration [APExBIO].
• HO-1 inhibition by Tin Mesoporphyrin IX (chloride) is instrumental in dissecting mechanisms of HBV replication and oxidative stress responses [Koyaweda et al., 2026].

For a scenario-driven, protocol-focused discussion on laboratory integration, see the guide on Solving Laboratory Challenges with Tin Mesoporphyrin IX (chloride), which offers step-by-step implementation details. This article extends that content by providing a comprehensive mechanistic and translational context.

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) (SKU C5606) is primarily used in biochemical, metabolic, and virological research to probe the HO pathway. Applications include:

• HO activity assays in cell and tissue extracts.
• Metabolic disease modeling, including studies on insulin resistance and metaflammation [Strategic Heme Oxygenase Inhibition].
• Virological research, especially in the context of HBV replication where HO-1 modulation alters viral morphogenesis [Koyaweda et al., 2026].
• Investigation of heme metabolism and downstream regulatory enzymes.

For a broader translational perspective, the article Strategic Inhibition of Heme Oxygenase offers an advanced rationale connecting HO-1’s role in pathogenesis to actionable research strategies. This current article updates those frameworks by incorporating the latest evidence on HBV and metabolic disease models.

Common Pitfalls or Misconceptions

• Not a therapeutic agent: No clinical trials are reported; use is limited to research settings.
• HO isoform selectivity: Tin Mesoporphyrin IX (chloride) inhibits both HO-1 and HO-2, not exclusively HO-1.
• Solubility constraints: Exceeding recommended concentrations in DMSO or DMF may result in precipitation or assay artifacts.
• Stability: Solutions are for short-term use only; long-term storage may reduce efficacy.
• Not effective in non-heme oxygenase-driven pathways: Ineffective where heme catabolism is not a primary regulatory mechanism.

Workflow Integration & Parameters

APExBIO supplies Tin Mesoporphyrin IX (chloride) (SKU C5606) as a crystalline solid with a molecular weight of 754.3 (C34H34Cl2N4O4Sn·2H). For use in HO activity assays, dissolve up to 0.5 mg/ml in DMSO or 1 mg/ml in dimethyl formamide. Store dry compound at -20°C; solutions should be freshly prepared and used promptly for optimal stability. In cell-based assays, titrate concentrations to minimize off-target or cytotoxic effects, typically beginning in the low nanomolar range to match reported Ki values. For animal studies, reference validated doses (1 pmol/kg) and ensure regulatory compliance. For advanced applications and comparative performance data, see Reliable Heme Oxygenase Inhibition—this article emphasizes mechanism and translational impact over assay logistics.

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) is a validated, potent inhibitor of heme oxygenase, widely adopted in metabolic and virological research. Its high affinity, chemical stability, and clear usage parameters make it a tool of choice for dissecting the HO pathway. While not approved for therapeutic use, it remains central to research on metabolic disease, insulin resistance, and viral pathogenesis models. Future research may further clarify isoform selectivity and expand applications in complex disease systems. For product details, protocols, and ordering, refer to the official Tin Mesoporphyrin IX (chloride) product page from APExBIO.